老年人RSV疫苗接种：一种通径分析方法

IF 4.5 3区医学 Q2 IMMUNOLOGY

Vaccine Pub Date : 2025-07-22 DOI:10.1016/j.vaccine.2025.127505

Filip Viskupič , David L. Wiltse , Gemechis Djira

{"title":"老年人RSV疫苗接种：一种通径分析方法","authors":"Filip Viskupič , David L. Wiltse , Gemechis Djira","doi":"10.1016/j.vaccine.2025.127505","DOIUrl":null,"url":null,"abstract":"<div><div>In May 2023, the first respiratory syncytial virus (RSV) vaccines were approved for adults 60 years and older in the United States. In April 2024, we fielded a survey in the state of South Dakota to investigate RSV vaccine uptake among this vulnerable population group. The survey measured RSV vaccine uptake, uptake of other vaccines, and other social and political variables associated with vaccine uptake. We analyzed the data using path analysis in SAS statistical software. The sample consisted of 376 participants 60 years and older. Of those, 33 % received the RSV vaccine. Path analysis results showed direct associations between RSV vaccine uptake and COVID-19 vaccine uptake (standardized effect of 0.2548, <em>p</em> < 0.0001) and flu vaccine uptake (standardized effect of 0.1883, <em>p</em> = 0.0001), as well as indirect associations between partisan self-identification (standardized effect of −0.1354, <em>p</em> < 0.0001) and trust in government (standardized effect of 0.0969, p < 0.0001).</div></div>","PeriodicalId":23491,"journal":{"name":"Vaccine","volume":"62 ","pages":"Article 127505"},"PeriodicalIF":4.5000,"publicationDate":"2025-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"RSV vaccine uptake among seniors: A path analysis approach\",\"authors\":\"Filip Viskupič , David L. Wiltse , Gemechis Djira\",\"doi\":\"10.1016/j.vaccine.2025.127505\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>In May 2023, the first respiratory syncytial virus (RSV) vaccines were approved for adults 60 years and older in the United States. In April 2024, we fielded a survey in the state of South Dakota to investigate RSV vaccine uptake among this vulnerable population group. The survey measured RSV vaccine uptake, uptake of other vaccines, and other social and political variables associated with vaccine uptake. We analyzed the data using path analysis in SAS statistical software. The sample consisted of 376 participants 60 years and older. Of those, 33 % received the RSV vaccine. Path analysis results showed direct associations between RSV vaccine uptake and COVID-19 vaccine uptake (standardized effect of 0.2548, <em>p</em> < 0.0001) and flu vaccine uptake (standardized effect of 0.1883, <em>p</em> = 0.0001), as well as indirect associations between partisan self-identification (standardized effect of −0.1354, <em>p</em> < 0.0001) and trust in government (standardized effect of 0.0969, p < 0.0001).</div></div>\",\"PeriodicalId\":23491,\"journal\":{\"name\":\"Vaccine\",\"volume\":\"62 \",\"pages\":\"Article 127505\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2025-07-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vaccine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0264410X25008023\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vaccine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0264410X25008023","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

2023年5月，首个呼吸道合胞病毒（RSV）疫苗在美国被批准用于60岁及以上的成年人。2024年4月，我们在南达科他州进行了一项调查，调查这一易感人群中RSV疫苗的接种情况。该调查测量了RSV疫苗的摄取、其他疫苗的摄取以及与疫苗摄取相关的其他社会和政治变量。采用SAS统计软件中的通径分析法对数据进行分析。样本由376名60岁及以上的参与者组成。其中33%的人接种了呼吸道合胞病毒疫苗。通径分析结果显示RSV疫苗摄取与COVID-19疫苗摄取之间存在直接关联(标准化效应为0.2548,p <；0.0001)和流感疫苗接种（标准化效应为0.1883,p = 0.0001），以及党派自我认同之间的间接关联(标准化效应为- 0.1354,p <；0.0001)和政府信任(标准化效应为0.0969,p <；0.0001)。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

RSV vaccine uptake among seniors: A path analysis approach

In May 2023, the first respiratory syncytial virus (RSV) vaccines were approved for adults 60 years and older in the United States. In April 2024, we fielded a survey in the state of South Dakota to investigate RSV vaccine uptake among this vulnerable population group. The survey measured RSV vaccine uptake, uptake of other vaccines, and other social and political variables associated with vaccine uptake. We analyzed the data using path analysis in SAS statistical software. The sample consisted of 376 participants 60 years and older. Of those, 33 % received the RSV vaccine. Path analysis results showed direct associations between RSV vaccine uptake and COVID-19 vaccine uptake (standardized effect of 0.2548, p < 0.0001) and flu vaccine uptake (standardized effect of 0.1883, p = 0.0001), as well as indirect associations between partisan self-identification (standardized effect of −0.1354, p < 0.0001) and trust in government (standardized effect of 0.0969, p < 0.0001).

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Vaccine 医学-免疫学

CiteScore

8.70

自引率

5.50%

发文量

992

审稿时长

131 days

期刊介绍： Vaccine is unique in publishing the highest quality science across all disciplines relevant to the field of vaccinology - all original article submissions across basic and clinical research, vaccine manufacturing, history, public policy, behavioral science and ethics, social sciences, safety, and many other related areas are welcomed. The submission categories as given in the Guide for Authors indicate where we receive the most papers. Papers outside these major areas are also welcome and authors are encouraged to contact us with specific questions.